Free triiodothyronine to free thyroxine ratio as a marker of poor prognosis in euthyroid patients with acute coronary syndrome and diabetes after percutaneous coronary intervention.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shen,Wang

第一单位： Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

作者： Shen,Wang ^[1] ; Yue,Wang ^[1] ; Shuaifeng,Sun ^[1] ; Fadong,Li ^[1] ; Wenxin,Zhao ^[1] ; Xinjian,Li ^[1] ; Maomao,Ye ^[1] ; Yufei,Niu ^[1] ; Xiaofan,Wu ^[1]

作者单位： Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. ^[1]

关键词 FT3/FT4 ratio acute coronary syndrome diabetes percutaneous coronary intervention prognosis

主题词人类(Humans);急性冠状动脉综合征(Acute Coronary Syndrome);男(雄)性(Male);女(雌)性(Female);三碘甲状腺原氨酸(Triiodothyronine);中年人(Middle Aged);预后(Prognosis);甲状腺素(Thyroxine);老年人(Aged);糖尿病(Diabetes Mellitus);甲状腺功能试验(Thyroid Function Tests);随访研究(Follow-Up Studies)

DOI 10.3389/fendo.2024.1322969

PMID 38654927

发布时间 2024-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in endocrinology

2024年15卷

1322969页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Free triiodothyronine to free thyroxine ratio as a marker of poor prognosis in euthyroid patients with acute coronary syndrome and diabetes after percutaneous coronary intervention.

Frontiers in endocrinology

相似文献

Frontiers in endocrinology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Free triiodothyronine to free thyroxine ratio as a marker of poor prognosis in euthyroid patients with acute coronary syndrome and diabetes after percutaneous coronary intervention.

Frontiers in endocrinology

相似文献

Frontiers in endocrinology

相关期刊

检索历史清除